Exact Mass: 533.1838282000001
Exact Mass Matches: 533.1838282000001
Found 276 metabolites which its exact mass value is equals to given mass value 533.1838282000001
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
N-(3,4-Dichlorophenyl)-2-{[5-(2,6-dioxo-1,3-dipropyl-2,3,6,9-tetrahydro-1H-purin-8-yl)-1-methyl-1H-pyrazol-3-yl]oxy}acetamide
(2r)-1,1,1-Trifluoro-2-{4-[(2s)-2-{[(3s)-3-Methylmorpholin-4-Yl]methyl}-4-(Thiophen-2-Ylsulfonyl)piperazin-1-Yl]phenyl}propan-2-Ol
C23H30F3N3O4S2 (533.1629736000001)
2,3,9,10-tetramethoxy-4-O-beta-D-glucopyranosyl-tetrahydroprotoberberine|thaicanine-4-O-beta-D-glucopyranoside
7-[(beta-D-apiofuranosyl-(1?6)-beta-D-glucopyranosyl)oxymethy]-8,8-dimethyl-4,8-dihydrobenzo[1,4]thiazine-3,5-dione
14-Deoxy-12-(cysteine-S-yl)-andrographolide-3-O-sulfate
C23H35NO9S2 (533.1753140000001)
1,2,3,10-Tetramethoxy-9-(2-hydroxy-4,5-dimethoxybenzyloxy)oxoaporphine
4-[5-chloro-7-(3,5-dihydroxyhexanoyloxy)-3-[(1E,3E,5E)-hepta-1,3,5-trienyl]-7-methyl-6,8-dioxoisoquinolin-2-yl]butanoic acid
C27H32ClNO8 (533.1816342000001)
Ala Glu Glu Trp
Ala Glu Trp Glu
Ala Trp Glu Glu
Cys Glu Pro Trp
Cys Glu Trp Pro
Cys Phe His Gln
Cys Phe Gln His
Cys His Phe Gln
Cys His Gln Phe
Cys Pro Glu Trp
Cys Pro Trp Glu
Cys Gln Phe His
Cys Gln His Phe
Cys Trp Glu Pro
Cys Trp Pro Glu
Asp Asp Glu Arg
Asp Asp Arg Glu
Asp Asp Val Trp
Asp Asp Trp Val
Asp Glu Asp Arg
Asp Glu Arg Asp
Asp Arg Asp Glu
Asp Arg Glu Asp
Asp Val Asp Trp
Asp Val Trp Asp
Asp Trp Asp Val
Asp Trp Val Asp
Glu Ala Glu Trp
Glu Ala Trp Glu
Glu Cys Pro Trp
Glu Cys Trp Pro
Glu Asp Asp Arg
Glu Asp Arg Asp
Glu Glu Ala Trp
Glu Glu Glu Lys
Glu Glu Glu Gln
Glu Glu Lys Glu
Glu Glu Gln Glu
Glu Glu Trp Ala
Glu Lys Glu Glu
Glu Pro Cys Trp
Glu Pro Trp Cys
Glu Gln Glu Glu
Glu Arg Asp Asp
Glu Trp Ala Glu
Glu Trp Cys Pro
Glu Trp Glu Ala
Glu Trp Pro Cys
Phe Cys His Gln
Phe Cys Gln His
Phe His Cys Gln
Phe His Gln Cys
Phe Gln Cys His
Phe Gln His Cys
His Cys Phe Gln
His Cys Gln Phe
His Phe Cys Gln
His Phe Gln Cys
His Asn Thr Tyr
His Asn Tyr Thr
His Gln Cys Phe
His Gln Phe Cys
His Gln Ser Tyr
His Gln Tyr Ser
His Ser Gln Tyr
His Ser Tyr Gln
His Thr Asn Tyr
His Thr Tyr Asn
His Tyr Asn Thr
His Tyr Gln Ser
His Tyr Ser Gln
His Tyr Thr Asn
Lys Glu Glu Glu
Met Pro Thr Trp
C25H35N5O6S (533.2307930000001)
Met Pro Trp Thr
C25H35N5O6S (533.2307930000001)
Met Gln Gln Gln
Met Thr Pro Trp
C25H35N5O6S (533.2307930000001)
Met Thr Trp Pro
C25H35N5O6S (533.2307930000001)
Met Trp Pro Thr
C25H35N5O6S (533.2307930000001)
Met Trp Thr Pro
C25H35N5O6S (533.2307930000001)
Asn His Thr Tyr
Asn His Tyr Thr
Asn Asn Thr Trp
Asn Asn Trp Thr
Asn Gln Ser Trp
Asn Gln Trp Ser
Asn Ser Gln Trp
Asn Ser Trp Gln
Asn Thr His Tyr
Asn Thr Asn Trp
Asn Thr Trp Asn
Asn Thr Tyr His
Asn Trp Asn Thr
Asn Trp Gln Ser
Asn Trp Ser Gln
Asn Trp Thr Asn
Asn Tyr His Thr
Asn Tyr Thr His
Pro Cys Glu Trp
Pro Cys Trp Glu
Pro Glu Cys Trp
Pro Glu Trp Cys
Pro Met Thr Trp
C25H35N5O6S (533.2307930000001)
Pro Met Trp Thr
C25H35N5O6S (533.2307930000001)
Pro Thr Met Trp
C25H35N5O6S (533.2307930000001)
Pro Thr Trp Met
C25H35N5O6S (533.2307930000001)
Pro Trp Cys Glu
Pro Trp Glu Cys
Pro Trp Met Thr
C25H35N5O6S (533.2307930000001)
Pro Trp Thr Met
C25H35N5O6S (533.2307930000001)
Gln Cys Phe His
Gln Cys His Phe
Gln Glu Glu Glu
Gln Phe Cys His
Gln Phe His Cys
Gln His Cys Phe
Gln His Phe Cys
Gln His Ser Tyr
Gln His Tyr Ser
Gln Met Gln Gln
Gln Asn Ser Trp
Gln Asn Trp Ser
Gln Gln Met Gln
Gln Gln Gln Met
Gln Ser His Tyr
Gln Ser Asn Trp
Gln Ser Trp Asn
Gln Ser Tyr His
Gln Trp Asn Ser
Gln Trp Ser Asn
Gln Tyr His Ser
Gln Tyr Ser His
Arg Asp Asp Glu
Arg Asp Glu Asp
Arg Glu Asp Asp
Ser His Gln Tyr
Ser His Tyr Gln
Ser Asn Gln Trp
Ser Asn Trp Gln
Ser Gln His Tyr
Ser Gln Asn Trp
Ser Gln Trp Asn
Ser Gln Tyr His
Ser Trp Asn Gln
Ser Trp Gln Asn
Ser Tyr His Gln
Ser Tyr Gln His
Thr His Asn Tyr
Thr His Tyr Asn
Thr Met Pro Trp
C25H35N5O6S (533.2307930000001)
Thr Met Trp Pro
C25H35N5O6S (533.2307930000001)
Thr Asn His Tyr
Thr Asn Asn Trp
Thr Asn Trp Asn
Thr Asn Tyr His
Thr Pro Met Trp
C25H35N5O6S (533.2307930000001)
Thr Pro Trp Met
C25H35N5O6S (533.2307930000001)
Thr Trp Met Pro
C25H35N5O6S (533.2307930000001)
Thr Trp Asn Asn
Thr Trp Pro Met
C25H35N5O6S (533.2307930000001)
Thr Tyr His Asn
Thr Tyr Asn His
Val Asp Asp Trp
Val Asp Trp Asp
Val Trp Asp Asp
Trp Ala Glu Glu
Trp Cys Glu Pro
Trp Cys Pro Glu
Trp Asp Asp Val
Trp Asp Val Asp
Trp Glu Ala Glu
Trp Glu Cys Pro
Trp Glu Glu Ala
Trp Glu Pro Cys
Trp Met Pro Thr
C25H35N5O6S (533.2307930000001)
Trp Met Thr Pro
C25H35N5O6S (533.2307930000001)
Trp Asn Asn Thr
Trp Asn Gln Ser
Trp Asn Ser Gln
Trp Asn Thr Asn
Trp Pro Cys Glu
Trp Pro Glu Cys
Trp Pro Met Thr
C25H35N5O6S (533.2307930000001)
Trp Pro Thr Met
C25H35N5O6S (533.2307930000001)
Trp Gln Asn Ser
Trp Gln Ser Asn
Trp Ser Asn Gln
Trp Ser Gln Asn
Trp Thr Met Pro
C25H35N5O6S (533.2307930000001)
Trp Thr Asn Asn
Trp Thr Pro Met
C25H35N5O6S (533.2307930000001)
Trp Val Asp Asp
Tyr His Asn Thr
Tyr His Gln Ser
Tyr His Ser Gln
Tyr His Thr Asn
Tyr Asn His Thr
Tyr Asn Thr His
Tyr Gln His Ser
Tyr Gln Ser His
Tyr Ser His Gln
Tyr Ser Gln His
Tyr Thr His Asn
Tyr Thr Asn His
Ethyl 1-(2-chlorophenyl)-5-(4-{4-[(3,5-dimethyl-1,2-oxazol-4-yl)c arbonyl]-1-piperazinyl}phenyl)-1H-pyrazole-3-carboxylate
N-acetylneuraminic Acid Methyl Ester 2,4,7,8,9-Pentaacetate
Idarubicin hydrochloride
C26H28ClNO9 (533.1452508000001)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors Idarubicin hydrochloride is an anthracycline antileukemic agent. It inhibits the topoisomerase II interfering with the replication of DNA and RNA transcription. Idarubicin hydrochloride inhibits the growth of bacteria and yeasts.
N-{2-[4-({3-Chloro-4-[3-(trifluoromethyl)phenoxy]phenyl}amino)-5H -pyrrolo[3,2-d]pyrimidin-5-yl]ethyl}-2-hydroxy-2-methylpropanamid e
C25H23ClF3N5O3 (533.1441434000001)
Melphalan flufenamide hydrochloride
D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor
((4-((4-Amino-m-tolyl)(4-(phenylimino)cyclohexa-2,5-dien-1-ylidene)methyl)phenyl)amino)benzenesulphonic acid
C32H27N3O3S (533.1773032000001)
2-Cyclohexyl-N-(2-{4-[5-(2,3-dichloro-phenyl)-2H-pyrazol-3-YL]-piperidin-1-YL}-2-oxo-ethyl)-2-guanidino-acetamide
C25H33Cl2N7O2 (533.2072658000001)
2-{[4-(2-Acetylamino-2-pentylcarbamoyl-ethyl)-naphthalen-1-YL]-oxalyl-amino}-benzoic acid
(2r)-1,1,1-Trifluoro-2-{4-[(2s)-2-{[(3s)-3-Methylmorpholin-4-Yl]methyl}-4-(Thiophen-2-Ylsulfonyl)piperazin-1-Yl]phenyl}propan-2-Ol
C23H30F3N3O4S2 (533.1629736000001)
[2-[2-(4-Fluorophenyl)ethylamino]-2-oxoethyl] 2-morpholin-4-yl-5-piperidin-1-ylsulfonylbenzoate
[4-[Bis(4-morpholinyl)phosphoryl]-1-methyl-2-pyrrolyl]-bis(4-morpholinyl)-sulfanylidenephosphorane
N-Benzoyl-N-(18-phenyl-11-oxa-13,15-diazatetracyclo[8.8.0.02,7.012,17]octadeca-1(10),2,4,6,8,12,14,16-octaen-16-yl)benzamide
N-[(2S,3S)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide
gammaGluCys(IAN)Glu
A tripeptide that consists of L-gamma-glutamyl-L-cysteinyl-L-glutamic acid in which the the cysteine side chain is substituted by a cyano(indol-3-yl)methyl group.
N-[(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide
C27H33Cl2N3O4 (533.1847998000001)
N-[(2R,3R)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide
N-[(2R,3R)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide
N-[(2S,3S)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide
N-[(2S,3R)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide
N-[(2S,3R)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide
N-[(2R,3S)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide
N-[(2R,3R)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide
N-[(2S,3R)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide
N-[(2R,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide
N-[(2R,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide
(2S,3S,4S,5R)-6-[3-[(4-acetamidophenyl)sulfonylamino]-2-phenylpyrazol-1-ium-1-yl]-3,4,5-trihydroxyoxane-2-carboxylic acid
6-[4-(2-{[2-(3,4-dimethoxyphenyl)ethyl]-C-hydroxycarbonimidoyl}eth-1-en-1-yl)-2-methoxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
(7R,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
C26H28ClNO9 (533.1452508000001)
4-[5-chloro-7-(3,5-dihydroxyhexanoyloxy)-3-[(1E,3E,5E)-hepta-1,3,5-trienyl]-7-methyl-6,8-dioxoisoquinolin-2-yl]butanoic acid
C27H32ClNO8 (533.1816342000001)
Idarubicin hydrochloride
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors Idarubicin hydrochloride is an anthracycline antileukemic agent. It inhibits the topoisomerase II interfering with the replication of DNA and RNA transcription. Idarubicin hydrochloride inhibits the growth of bacteria and yeasts.
3-L-tryptophyl-AMP
An L-tryptophan derivative that is the ester obtained by formal condensation of the carboxy group of L-tryptophan with the 3-hydroxy group of AMP.
(15e)-5,8,18,21-tetrahydroxy-6-isopropyl-20-[2-(methylsulfanyl)ethyl]-2-oxa-11,12-dithia-7,19,22-triazabicyclo[7.7.6]docosa-7,15,18,21-tetraen-3-one
C22H35N3O6S3 (533.1687890000001)
(3s,6s,9r,13s,18as)-16-chloro-3,13-diethyl-1,4,7,11-tetrahydroxy-6-(hydroxymethyl)-9-phenyl-3h,6h,9h,10h,13h,18h,18ah-pyrrolo[1,2-d]1,4,7,10,13-pentaazacyclohexadecan-14-one
C25H32ClN5O6 (533.2041002000001)